1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Exosome diagnostic and therapeutic Market – By Application

1.3.2        Asia Pacific Exosome diagnostic and therapeutic Market – By Product

1.3.3        Asia Pacific Exosome diagnostic and therapeutic Market – By End User

1.3.4        Asia Pacific Exosome Diagnostic and Therapeutic Market – By Geography

2.          Exosome Diagnostic And Therapeutic Market –  Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Exosome Diagnostic and Therapeutic Market – Market Landscape

4.1        Overview

4.2        Pest Analysis

4.2.1        Asia Pacific– PEST Analysis

5.          Exosome Diagnostic and Therapeutic Market – Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

5.1.2        Rise in Research and Development Activities

5.2        Key Market Restraints

5.2.1        Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes

5.3        Key Market Opportunities

5.3.1        Growing Preference for Non-invasive and Novel Diagnostic Procedures

5.4        Future Trends

5.4.1        Automation of Exosome Isolation Process

5.5        Impact analysis

6.          Exosome Diagnostic and Therapeutic Market Analysis – By Application

6.1        Overview

6.2        Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

6.3        Diagnostic

6.3.1        Overview

6.3.2        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

6.4        Therapeutic

6.4.1        Overview

6.4.2        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

7.          Exosome Diagnostic and Therapeutic Market Analysis – By Product

7.1        Overview

7.2        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)

7.3        Instruments

7.3.1        Overview

7.3.2        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

7.4        Reagents

7.4.1        Overview

7.4.2        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

7.5        Software

7.5.1        Overview

7.5.2        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.          Exosome Diagnostic and Therapeutic Market Analysis – By End User

8.1        Overview

8.2        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)

8.3        Cancer Institutes

8.3.1        Overview

8.3.2        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.4        Hospitals

8.4.1        Overview

8.4.2        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.5        Diagnostic Centres

8.5.1        Overview

8.5.2        Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.6        Other End User

8.6.1        Overview

8.6.2        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.          Exosome Diagnostic and Therapeutic Market – Country Analysis

9.1        Asia Pacific: Exosome Diagnostic and Therapeutic Market

9.1.1        Overview

9.1.2        Asia Pacific: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)

9.1.3        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousands)

9.1.4        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.5        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.6        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

9.1.7        China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.7.1         China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.7.1.1         China: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.7.1.2         China: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.7.1.3         China: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.8        Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.8.1         Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.8.1.1         Japan: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.8.1.2         Japan: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.8.1.3         Japan: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.9        India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.9.1         India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.9.1.1         India: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.9.1.2         India: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.9.1.3         India: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.10     South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.10.1       South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.10.1.1       South Korea: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.10.1.2       South Korea: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.10.1.3       South Korea: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

9.1.11     Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.11.1       Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

9.1.11.1.1       Australia: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

9.1.11.1.2       Australia: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

9.1.11.1.3       Australia: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.       Impact of COVID-19 Pandemic on Asia Pacific Exosome Diagnostic and Therapeutic Market

10.1     Asia-Pacific: Impact assessment of COVID-19 Pandemic

11.       Company Profiles

11.1     Cell Guidance Systems

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     BIOREGENERATIVE SCIENCES

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     Evomic Science LLC

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4     Norgen Biotek Corp

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     Miltenyi Biotec

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6     AETHLON MEDICAL, INC

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7     EXOSOME DIAGNOSTICS

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

LIST OF TABLES

Table 1.            Asia Pacific Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousands)

Table 2.            Asia Pacific Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 3.            Asia Pacific Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 4.            China Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 5.            China Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 6.            China Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 7.            Japan Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 8.            Japan Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 9.            Japan Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 10.         India Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 11.         India Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 12.         India Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 13.         South Korea Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 14.         South Korea Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 15.         South Korea Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 16.         Australia Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027 (USD Thousand)

Table 17.         Australia Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 18.         Australia Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 19.         Glossary of Terms, Exosome diagnostic and treatment market

LIST OF FIGURES

Figure 1.          Exosome Diagnostic and Therapeutic Market Segmentation

Figure 2.          Exosome Diagnostic and Therapeutic Segmentation, By Region

Figure 3.          Asia Pacific Exosome Diagnostic and Therapeutic Market Overview

Figure 4.          Diagnostics Held Largest Share Of Application Segment In Exosome diagnostic and Therapeutic Market

Figure 5.          China Is Expected to Show Remarkable Growth during the Forecast Period

Figure 6.          Asia pacific PEST Analysis

Figure 7.          Exosome diagnostic and therapeutic market impact analysis of driver and restraints

Figure 8.          Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

Figure 9.          Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 10.        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 11.        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)

Figure 12.        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 13.        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 14.        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 15.        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)

Figure 16.        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 17.        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 18.        Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 19.        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 20.        Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 21.        Asia Pacific Exosome Diagnostic and Therapeutic Market Revenue and Forecast to 2027 (USD Thousands)

Figure 22.        China: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 23.        Japan: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 24.        India: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 25.        South Korea: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 26.        Australia: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 27.          Impact of COVID-19 Pandemic in Asia-Pacific Country Markets